关键词: covid-19 female sexual dysfunction fsfi griss vaginismus

来  源:   DOI:10.7759/cureus.52612   PDF(Pubmed)

Abstract:
Background The objective of this study conducted at one center is to compare the demographic features and female sexual functions of patients treated for vaginismus before the COVID-19 pandemic to those treated for vaginismus during the pandemic. Aim Additionally, the study intends to evaluate the results of vaginismus therapy and assess the post-treatment sexual functioning of women. Methods A retrospective analysis was conducted on the medical records of patients diagnosed with vaginismus who sought treatment between March 2018 and March 2022. The enrolled patients were categorized into two groups: the pre-COVID-19 group and the COVID-19 group. The following data have been collected: age, education level, occupation, and marriage duration. After three months of treatment, the patients were called for a follow-up examination and evaluation of their sexual functions. Outcomes Compared to the pre-COVID-19 group, an increase of 52.51% was observed in the number of patients admitted for treatment in the COVID-19 group. Results The severity of vaginismus in the patients was similar in both groups. There were no statistically significant changes observed in any of the areas of the Female Sexual Function Index (FSFI) scale. Clinical implications According to our findings, there was no significant difference in female sexual functioning between women who had vaginismus treatment during the pandemic and those who underwent pre-pandemic treatment. Strengths and limitations The research sample comprised women who sought medical care at our women\'s health clinic. Conclusions We believe that vaginismus patients who had previously avoided seeking treatment are now seeking it during the pandemic.
摘要:
背景在一个中心进行的这项研究的目的是比较COVID-19大流行前接受阴道痉挛治疗的患者与大流行期间接受阴道痉挛治疗的患者的人口统计学特征和女性性功能。此外,该研究旨在评估阴道痉挛治疗的结果,并评估治疗后女性的性功能。方法回顾性分析2018年3月-2022年3月就诊的经确诊的阴道痉挛患者的病历资料。将入选的患者分为两组:COVID-19组和COVID-19组。收集了以下数据:年龄,教育水平,职业,和婚姻持续时间。经过三个月的治疗,患者被要求进行随访检查和评估其性功能。结果与COVID-19之前的组相比,COVID-19组接受治疗的患者数量增加了52.51%.结果两组患者的阴道痉挛严重程度相似。在女性性功能指数(FSFI)量表的任何区域均未观察到统计学上的显着变化。临床意义根据我们的发现,在大流行期间接受阴道痉挛治疗的女性和接受大流行前治疗的女性性功能没有显著差异.优点和局限性研究样本包括在我们的妇女健康诊所寻求医疗护理的妇女。结论我们认为,以前避免寻求治疗的阴道痉挛患者现在正在大流行期间寻求治疗。
公众号